written on 01.02.2019

Algeria Pharma Report 2019


Topics covered in this report – which features the exclusive insights of government ministers, the heads of local pharma champions as well as multinational affiliate leaders – include the potential impact of Algeria’s sweeping new healthcare law, the establishment of the country’s first National Cancer Plan, global companies’ scramble to localise manufacturing operations, an investment wave from the Middle East, and Algeria’s ramped-up export capabilities.

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here